# Therapeutic Potential of Cynara scolymus Extract and Bifidobacterium longum in Alleviating Diabetes-Induced Male Reproductive Dysfunction

**Authors:** Hadis Bozorgpoursavadjani, Haniyeh Keyghobadi, Delaram Moghadam, Reza Zare, Farshad Dehghani, Iman Jamhiri, Farhad Koohpeyma, Sanaz Dastghaib

PMC · DOI: 10.1155/ije/5884930 · 2025-10-19

## TL;DR

This study explores how Cynara scolymus extract and Bifidobacterium longum probiotic can help reduce diabetes-related damage to male reproductive health in rats.

## Contribution

The novel contribution is the demonstration of combined Cynara and Bifidobacterium longum treatment's superior protective effect on diabetic male reproductive dysfunction.

## Key findings

- Combined Cynara and Bifidobacterium longum treatment significantly reduced blood sugar and oxidative stress in diabetic rats.
- The combination increased testosterone and key steroidogenesis enzyme mRNA expressions more than individual treatments.
- Histological improvements in testicular structure were observed with combination therapy.

## Abstract

Diabetes mellitus (DM) is associated with a number of adverse effects on male reproductive health, including oxidative stress, testosterone deficiency, and spermatogenesis defects. Natural and probiotic-based therapies have gained popularity as a means of alleviating DM-related complications.

Streptozotocin (60 mg/kg) was employed to induce diabetes in male Sprague-Dawley rats, which were then divided into eight groups, each receiving hydroalcoholic Cynara scolymus (Cynara) extract, Bifidobacterium longum (BBL) probiotic or a combination of both. The following parameters were measured: Fasting blood sugar (FBS), serum malondialdehyde (MDA), serum sexual hormones, and testicular MDA and total antioxidant capacity (TAC), as well as mRNA expressions of steroidogenesis enzymes Star, Cyp11a1, and Hsd17b3. Histopathological study and modified Johnson scoring system were performed.

Rats with diabetes treated with Cynara, BBL, and their combination showed a substantial reduction in FBS and MDA levels as well as an increase in TAC when compared to the diabetic group. The combined treatment demonstrated a greater elevation in serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone levels in comparison to individual treatments. The mRNA expressions of Star, Cyp11a1, and Hsd17b3 increased significantly in the combined treatment group. Histological assessments revealed improved testicular architecture and germ cell populations in the combination therapy group.

Cynara and BBL treatments in diabetic rats in combination produced a powerful protective effect on male reproductive function. The results showed that Cynara and BBL could be considered as promising therapeutic agents able to reduce the detrimental effects of diabetes on male reproductive health. Further research is needed to define their precise mechanisms and potential clinical uses.

## Linked entities

- **Genes:** STAR (steroidogenic acute regulatory protein) [NCBI Gene 6770], CYP11A1 (cytochrome P450 family 11 subfamily A member 1) [NCBI Gene 1583], HSD17B3 (hydroxysteroid 17-beta dehydrogenase 3) [NCBI Gene 3293]
- **Chemicals:** Streptozotocin (PubChem CID 29327), malondialdehyde (PubChem CID 10964), testosterone (PubChem CID 6013), follicle-stimulating hormone (PubChem CID 62819)
- **Diseases:** Diabetes mellitus (MONDO:0005015)

## Full-text entities

- **Diseases:** testosterone deficiency (MESH:D007153), Male Reproductive Dysfunction (MESH:D005832), spermatogenesis defects (MESH:C536875), DM (MESH:D003920)
- **Chemicals:** testosterone (MESH:D013739), Streptozotocin (MESH:D013311), MDA (MESH:D008315), hydroalcoholic (-)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Bifidobacterium longum (species) [taxon 216816]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12554919/full.md

---
Source: https://tomesphere.com/paper/PMC12554919